ArticleCureus2024
Iatrogenic Botulism Following Botulinum Toxin Injection as an Adjunct to Abdominal Wall Reconstruction for Incisional Hernia.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Intraoperative Fascial Traction - From Concept to Comprehensive Application.Journal of abdominal wall surgery : JAWS · 2026Review
- Article
- Preoperative Botulinum Toxin A and Its Impact on Pulmonary Function in Giant Abdominal Wall Hernias: A Prospective Spirometry-Based Analysis.Journal of abdominal wall surgery : JAWS · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Open ventral hernia repair is one of the most commonly performed surgeries by general surgeons worldwide. In the case of complex incisional hernias, there are adjunct techniques that can help abdominal wall reconstruction surgery, such as type A botulinum toxin (BTA), whose injection results in muscle relaxation and growth of muscle fiber length, allowing fascial closure without the need for advanced techniques. We report a case of a male patient who underwent ultrasound-guided BTA injection in the abdominal wall and, five days later, was admitted to our emergency department with dysarthria, muscular weakness, dyspnea on small exertion, and constipation. There was a rapid worsening of respiratory failure, requiring invasive mechanical ventilation. After the exclusion of other neurological conditions, iatrogenic botulism was assumed to be the most likely cause. There are adjunct tools that allow successful abdominal wall reconstruction, such as BTA, which is relatively safe. On rare occasions, systemic absorption of BTA can lead to systemic effects, such as iatrogenic botulism, that can be extremely severe. We have not found any case reports about iatrogenic botulism related to BTA use in abdominal wall musculature. This is the first documented case of iatrogenic botulism related to BTA injection in the abdominal wall musculature. Given its severity, it is important that surgeons working with BTA are aware of these potential complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.